Brain Cancer
Astrocytoma
Male, 35 years
Patient Internal 1292762649
ICD-10 code
C71.1 Malignant Neoplasm of Frontal Lobe
Diagnosis (Incl. Metastases/Stage) and Year
April 2021
Astrocytoma, WHO grade 4, IDH1/2 mutations. The tumor spread to the Left Frontotemporal Lobe.
Previous Treatment
Surgery, Radiation Therapy, Chemotherapy (Temozolomide).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of ~14 months from diagnosis.
Treatment Provided
Autologous DCV (4 doses) and CIK (4 doses) with Interleukin-2 over a period of 2 months.
Additionally, the patient received Nasal Drops of Exosomes with Paclitaxel.
Patient Survival/Condition and Year
Date of Review: 01/02/2024
The patient has survived for 34 months since the diagnosis. Since the beginning of the disease, the patient suffered neurological symptoms, however, the latest MRI scan shows no noticeable disease progression. It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapy and Radiation Therapy, has extended patient survival by an estimate of around 20 months so far.
